排序方式: 共有50条查询结果,搜索用时 0 毫秒
1.
心脏纤维化会引发心脏舒张和收缩障碍,诱发心律失常,增加心血管疾病患者的再入院率和死亡风险。成纤维细胞是维持和促进心脏组织细胞外基质沉积的主要细胞类型,并且对力学微环境改变敏感。最近的研究揭示了力学因素影响成纤维细胞功能的具体力学信号转导通路。文章对此进行了综述,并就体外力学模型和临床研究进展进行了适当讨论。 相似文献
2.
3.
目的:观察同型半胱氨酸(Hcy)对外周血内皮祖细胞(EPCs)的影响。方法: 密度梯度离心法获取外周血单个核细胞,将其接种在人纤维连接蛋白包被的培养板,培养7 d后,收集贴壁细胞,加入不同浓度Hcy(10 μmol/L、50 μmol/L、100 μmol/L和200 μmol/L)干预一定时间(6 h、12 h、24 h和48 h)。多波长激光共聚焦显微镜鉴定FITC-UEA-Ⅰ和DiI-acLDL双染色阳性细胞为正在分化的EPCs,流式细胞仪检测其表面标志进一步鉴定EPCs,倒置荧光显微镜下计数。采用MTT比色法、改良的Boyden小室、粘附能力测定实验和体外血管生成试剂盒分别观察EPCs的增殖能力、迁移能力、粘附能力和体外血管生成能力。结果:Hcy呈量效和时效地减少EPCs数量,200 μmol/L Hcy作用24 h后EPCs数量明显少于对照组(35.7±6.7 vs 62.5±10.6,P<0.01),并损害EPCs增殖(0.531±0.061 vs 0.328±0.055,P<0.01)、迁移(26.3±6.4 vs 6.4±3.7,P<0.01)、贴壁(33.1±8.1 vs 17.4±7.5,P<0.01)、和体外血管生成(25.4±9.1 vs 10.4±4.7,P<0.01)。 结论: Hcy不但减少EPCs数量并损害其功能。 相似文献
4.
【目的】探讨在幼猪体外循环期间应用以氟碳化合物乳剂为媒介的部分液体通气模式对体外循环后幼猪肺组织气体交换的影响以及病理改变。【方法】18只幼猪随机分为3组,Ⅰ组为对照组,即单纯体外循环(CPB)组;Ⅱ组于体外循环期间在肺内灌入5 mL/kg的氟碳化合物OxygentTM;Ⅲ组于体外循环期间在肺内灌入15 mL/kg OxygentTM。分别在CPB前、停CPB 5 min及停CPB后0.5、1、1.5、2 h观察动脉血气指标以及肺动态顺应性的变化,并计算氧合指数。实验结束后取右肺下叶基底段做病理切片。【结果】与对照组比较,Ⅱ组停CPB后0.5、1、1.5、2 h时点动脉血氧分压(Pa,O 2)明显升高,氧合指数明显增加,肺顺应性明显改善(P<0.05)。Ⅲ组与对照组无明显差异。病理切片比较,小剂量组(Ⅱ组)病变轻于对照组和Ⅲ组。【结论】在幼猪CPB期间应用小剂量(5 mL/kg)OxygentTM进行部分液体通气,可明显地改善体外循环后其肺氧合能力,改善肺顺应性,减轻肺部的病理改变。 相似文献
5.
6.
【目的】探讨冠状动脉旁路移植术后血管麻痹综合征患者的术后转归。【方法】24例冠状动脉旁路移植术后发生血管麻痹综合征的病人同时选入48例术后未发生血管麻痹的患者以1:2的比例行病例对照研究。【结果】与对照组相比,麻痹组术后12h胸腔引流液,心律失常的发生率,IABP安装率显著增多(P<0.05),术后机械通气时间、ICU滞留时间、住院时间麻痹组亦较对照组明显延长(P<0.05)。【结论】冠状动脉旁路移植术后发生血管麻痹综合征的病人,其术后心律失常发生率,胸腔引流液,IABP使用率明显增多,机械通气时间、ICU滞留时间、住院时间明显延长。 相似文献
7.
SCN5A基因移码突变导致Brugada综合征 总被引:8,自引:1,他引:8
目的:检测Brugada综合征的致病基因突变位点。方法:对1个Brugada综合征家系11名成员和20名正常人的DNA样本应用双脱氧链终止基因测序法进行心脏钠离子通道α亚单位(voltage-gated sodium channel type V,SCN5A)基因测序。结果:SCN5A基因测序发现Brugada综合征家系第22个外显子存在1个杂合基因移码突变位点,经克隆传代后测序发现该突变为4087insC。该突变使通道蛋白1314-1317位氨基酸发生改变并在1318位终止,导致钠离子通道第3结构域S4结构变化,S5-6及第4结构域全部缺失。该突变在Brugada综合征家系中分布符合常染色体显性分布规律。对照组未发现相同突变。结论:SCN5A基因4087insC是国内首次发现的导致Brugada 综合征的基因突变位点,也是国际上发现的第2个引起Brugada综合征的SCN5A基因移码突变 相似文献
8.
Background The utilization value of intraoperative transesophageal echocardiography in cardiac surgery is more and more important. However,the role of intraoperative transesophageal echocardiography on quality control during thoracoscopic cardiac surgery has not been comprehensively studied. Methods A retrospective study of transesophageal echocardiography application on patients underwent thoracoscopic cardiac surgery from2012 to 2015 was conducted in a single cardiovascular center. General anesthesia and peripheral cardiopulmonary bypass were standardized for all patients. All procedures were performed through 3 holes made in the right chest wall. Transesophageal echocardiography monitoring was routinely utilized in each patient. Results A total of 1387 patients underwent thoracoscopic cardiac surgery were involved in the study. The mean age of patients was 42.8±15.3 years with a female predominance(60.6%). The most common procedures were mitral valve replacement(n=507,36.6%),atrial septal defect repair(n=425,30.6%),and mitral valve plasty(n=294,21.2%). Other main procedures included correction of partial anomalous pulmonary venous connection,cor triatriatum,ventricular septal defect or partial atrioventricular canal,removal of left or right atrial myxoma,and tricuspid valve plasty or replacement. Transesophageal echocardiography monitoring was useful at every stage of surgery without any major associated complications. Forty-four patients(3.2%)required surgical re-interventions immediately following transesophageal echocardiography evaluation. The reasons included unsatisfactory valve plasty,paravalvular leak,prosthetic dysfunction and residual shunting. The incidence of surgical re-intervention,as well as the mortality,decreased annually with increased surgical volume. Conclusions Intraoperative transesophageal echocardiography plays an important role in the quality control of thoracoscopic cardiac surgery.[S Chin J Cardiol 2019;20(2):69-78] 相似文献
9.
目的:研究血管紧张素转化酶抑制剂(angiotensin converting enzyme inhibitor,ACEI)咪达普利活性代谢物咪达普利拉对白细胞介素-1β(interleukin -1β,IL-1β)诱导的心脏成纤维细胞基质金属蛋白酶(matrix metalloproteinases,MMPs)和基质金属蛋白酶2型抑制剂(type 2 tissue inhibitor of matrix metalloproteinase,TIMP-2)表达的影响及其可能机制。方法:原代人心脏成纤维细胞从美国细胞应用所购买。用RT-PCR检测心脏成纤维细胞MMP-2、MMP-9和TIMP-2 mRNA水平的变化;用凝胶酶谱法分析心脏成纤维细胞中MMP-2、MMP-9的活性;用Griess方法检测培养上清一氧化氮(nitric oxide,NO)水平。结果:通过凝胶酶谱分析,RT-PCR和Griess方法发现IL-1β能显著增加MMP-2基因转录以及活性(P<0.05),同时也显著增加了细胞培养上清中NO的产生(P<0.05)。IL-1β的这些效应可以被咪达普利拉和外源性NO合酶抑制剂L-单甲基精氨酸(NG-methyl L-Arginine,L-NMMA)所抑制(P<0.05),而外源性NO供体亚硝基铁氰化钠(sodium nitroprusside,SNP)可以取消咪达普利拉对于NO、MMP-2的有效作用(P<0.05)。实验中发现IL-1β以及咪达普利拉对TIMP-2基因转录无明显作用(P>0.05)。结论:咪达普利拉能通过NO途径抑制IL-1β诱导的心脏成纤维细胞MMP-2的合成和活性;提示ACEI抗心肌重塑以及心力衰竭的部分作用可能是通过MMPs途径实现的。 相似文献
10.
The etiology of vasoplegic syndrome(VS) is not completely elucidated and the clinical importance remains speculative.Methods Twenty-four patients who underwent coronary artery bypass grafting and developed VS were compared with 48 control patients without VS in a 2:1 case control study.Cases and controls were matched by gender,age(± 5 years old) and operation date(± 1 week).Results The independent predictors of VS were lower ejection fraction(OR 10.75,95% CI 2.93-39.44,when LVEF 0.45) and diuretic use(OR 8.98,95% CI 2.59-31.10) in logistic regression analysis.Conclusion lower ejection fraction( 0.45) and diuretic use are independent risk factors for VS occurrence. 相似文献